However, this activity decreases in patients with chronic liver disease; thus, continuous glucagon infusion might be favorable as a treatment for hypoglycemia caused by non-islet cell tumor (14, 23). The gene discussed is GCG; the disease is pancreatic neuroendocrine tumor.